These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11003365)

  • 1. Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation.
    Jacobi J; Rockstroh J; John S; Schreiber M; Schlaich MP; Neumayer HH; Schmieder RE
    Transplantation; 2000 Sep; 70(5):819-27. PubMed ID: 11003365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four hour blood pressure profile and left ventricular hypertrophy early after renal transplantation.
    Marcondes AM; De Lima JJ; Giorgi DM; Vieira ML; de Andrade JL; Ianhez LE; Krieger EM
    Ren Fail; 2002 Mar; 24(2):207-13. PubMed ID: 12071594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
    Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
    Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
    Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension, antihypertensive agents and outcomes following renal transplantation.
    Tutone VK; Mark PB; Stewart GA; Tan CC; Rodger RS; Geddes CC; Jardine AG
    Clin Transplant; 2005 Apr; 19(2):181-92. PubMed ID: 15740553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
    Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
    Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST Observational Study.
    Salvadori M; Rosati A; Bock A; Chapman J; Dussol B; Fritsche L; Jeffery J; Kliem V; Lebranchu Y; Oppenheimer F; Pohanka E; Tufveson G
    Transplant Proc; 2003 Dec; 35(8):2863-7. PubMed ID: 14697923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database.
    Staessen JA; O'Brien ET; Amery AK; Atkins N; Baumgart P; De Cort P; Degaute JP; Dolenc P; De Gaudemaris R; Enström I
    J Hypertens Suppl; 1994; 12(7):S1-12. PubMed ID: 7769499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renal function in type I diabetics after kidney or kidney-pancreas transplantation: influence of number, timing, and treatment of acute rejection episodes.
    Hricik DE; Phinney MS; Weigel KA; Knauss TC; Schulak JA
    Transplantation; 1997 Nov; 64(9):1283-8. PubMed ID: 9371669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.
    Fellström B; Holdaas H; Jardine AG; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Staffler B; Pedersen TR;
    Transplantation; 2005 Jan; 79(2):205-12. PubMed ID: 15665769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of selected factors on long-term kidney graft survival--a multivariable analysis.
    Zukowski M; Kotfis K; Kaczmarczyk M; Biernawska J; Szydłowski L; Zukowska A; Sulikowski T; Sierocka A; Bohatyrewicz R
    Transplant Proc; 2014 Oct; 46(8):2696-8. PubMed ID: 25380897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center.
    Tinawi M; Miller L; Bastani B
    Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar impact of slow and delayed graft function on renal allograft outcome and function.
    Rodrigo E; Fernández-Fresnedo G; Ruiz JC; Piñera C; Palomar R; González-Cotorruelo J; Zubimendi JA; De Francisco AL; Sanz de Castro S; Arias M
    Transplant Proc; 2005 Apr; 37(3):1431-2. PubMed ID: 15866627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic factors have a major impact on kidney allograft survival.
    Hamar P; Müller V; Kohnle M; Witzke O; Albrecht KH; Philipp T; Heemann U
    Transplantation; 1997 Oct; 64(8):1135-9. PubMed ID: 9355829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
    Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation.
    MacPhee IA; Bradley JA; Briggs JD; Junor BJ; MacPherson SG; McMillan MA; Rodger RS; Watson MA
    Transplantation; 1998 Nov; 66(9):1186-92. PubMed ID: 9825816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.